Pharmacogenomics in cancer drug discovery and development: inhibitors of the Hsp90 molecular chaperone

P Workman - Cancer detection and prevention, 2002 - Elsevier
Drug discovery is being revolutionised by a number of technological developments. These
include high throughput screening, combinatorial chemistry and genomics. The impact of the
new technologies is to accelerate the pace of anticancer discovery. The completion of the
Human Genome Project and the ongoing high throughput sequencing of cancer genomes
will facilitate the identification of a range of new molecular targets for drug discovery. Over
the next few years we will have a complete molecular understanding of the various …